SEMS Placement Followed by Chemotherapy and Surgery for Obstructing Left-sided Colonic Cancer
- Conditions
- Complication of Treatment
- Registration Number
- NCT04039360
- Lead Sponsor
- Beijing Chao Yang Hospital
- Brief Summary
This study aimed to evaluate the safety and feasibility of SEMS followed by neoadjuvant chemotherapy prior to elective surgery for obstructing left-sided colon cancer.
- Detailed Description
Stoma is reported to be frequent in self-expanding metallic stent (SEMS) treated patients with obstructing left-sided colon cancer than in those with non-obstructing surgery. Retrospective study reported worse overall survival with SEMS and elective surgery than with emergency surgery in patients with left-sided malignant colon obstruction. In practice, intestinal wall edema following stent placement increases the difficulty of surgery, and this could be a major problem if the interval between stent insertion and surgery is short (1-2 weeks). The patients with obstructing left-sided colon cancer received SEMS treatment, and the recevied neoadjuvant chemotherapy prior to elective surgery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 11
- histologically proven adenocarcinoma located in the left colon (between the splenic flexure and 15 cm proximal to the anal margin)
- Eastern Cooperative Oncology Group (ECOG) performance status of from 0 to 2
- history of any other cancer
- multiple primary colorectal cancers
- distant metastases
- hereditary nonpolyposis colorectal cancer
- familial adenomatous polyposis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method stoma rate 3 years after operation stoma rate after surgery
- Secondary Outcome Measures
Name Time Method